| 雷贝拉唑联合莫沙必利治疗反流性食管炎的80例疗效观察 |
| |
| 引用本文： | 张杰.雷贝拉唑联合莫沙必利治疗反流性食管炎的80例疗效观察[J].亚太传统医药,2007,3(11):77-78. |
| |
| 作者姓名： | 张杰 |
| |
| 作者单位： | 雅安市人民医院消化科,四川,雅安,625000 |
| |
| 摘 要： | 目的:观察雷贝拉唑联合莫沙必利治疗反流性食管炎的近期疗效。方法:将确诊为返流性食管炎的患者随机分为两组,雷贝拉唑联合莫沙必利组和法莫替丁联合莫沙必利组,对其临床疗效进行观察研究。结果:雷贝拉唑联合莫沙必利组治疗反流性食管炎总有效率为95.24%,疗效显著高于法莫替丁联合莫沙必利组,且不良反应少。结论:雷贝拉唑联合莫沙必利治疗反流性食管炎疗效明显,安全可靠。
|
| 关 键 词： | 雷贝拉唑 莫沙必利 反流性食管炎 |
Effect of Treatment on 80 Cases of Reflux Esophagitis with the Joint Use of Rabeprazole and Mosapride |
| |
| Zhang Jie.Effect of Treatment on 80 Cases of Reflux Esophagitis with the Joint Use of Rabeprazole and Mosapride[J].Asia-Pacific Traditional Medicine,2007,3(11):77-78. |
| |
| Authors: | Zhang Jie |
| |
| Abstract: | Objective: To investigate the effect of the joint use of rabeprazole and mosapride in treating reflux esophagitis. Methods: Our hospital diagnosed as reflux esophagitis patients were randomly divided into two groups, rabeprazole joint mosapride group, famotidine joint mosapride group, and study on its clinical efficacy. Results: The total efficiency of the joint use of rabeprazole and mosapride in treating reflux esophagitis is 95.24%, it is significantly higher than that of famotidine Lactulose, and has fewer adverse reactions. Conclusion: The efficacy of the joint use of rabeprazole and mosapride in treating reflux esophagitis is obviously, and it's safe and reliable. |
| |
| Keywords: | Rabeprazole Mosapride Esophagitis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
